How are Ceftriaxone adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ceftriaxone is flagged as the suspect drug causing the adverse event.
What are the most common Ceftriaxone adverse events reported to the FDA?
Pyrexia | 423 (1.81%) |
Renal Failure Acute | 375 (1.61%) |
Rash | 311 (1.33%) |
Dyspnoea | 266 (1.14%) |
Pruritus | 229 (.98%) |
Anaphylactic Shock | 224 (.96%) |
Toxic Epidermal Necrolysis | 219 (.94%) |
Thrombocytopenia | 217 (.93%) |
Renal Failure | 204 (.87%) |
Drug Rash With Eosinophilia And Sys... | 200 (.86%) |
Urticaria | 184 (.79%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ceftriaxone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Ceftriaxone adverse events reported to the FDA?
Epidermal And Dermal Conditions | 2582 (11.06%) |
Hepatic And Hepatobiliary | 958 (4.1%) |
Infections - Pathogen Unspecified | 922 (3.95%) |
Respiratory | 909 (3.89%) |
Renal Disorders | 884 (3.79%) |
Neurological | 777 (3.33%) |
Hematology Investigations | 685 (2.93%) |
Allergic Conditions | 607 (2.6%) |
Gastrointestinal Signs | 568 (2.43%) |
Cardiac Arrhythmias | 558 (2.39%) |
Bacterial Infectious | 530 (2.27%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ceftriaxone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Ceftriaxone, according to those reporting adverse events to the FDA?
Drug Use For Unknown Indication | 868 |
Pneumonia | 749 |
Product Used For Unknown Indication | 495 |
Infection | 311 |
Urinary Tract Infection | 299 |
Pyrexia | 219 |
Show More |
Label | Labeler | Effective |
---|---|---|
Ceftriaxone | West-ward Pharmaceutical Corp | 26-AUG-09 |
Ceftriaxone | BAXTER HEALTHCARE CORPORATION | 22-FEB-10 |
Ceftriaxone | Bedford Laboratories | 30-MAR-10 |
Ceftriaxone | Bedford Laboratories | 30-MAR-10 |
Ceftriaxone Sodium | Apotex Corp. | 14-MAY-10 |
Rocephin | Genentech, Inc. | 02-DEC-10 |
Rocephin | Genentech, Inc. | 02-DEC-10 |
Ceftriaxone Sodium | Rebel Distributors Corp | 17-JAN-11 |
Ceftriaxone | LUPIN PHARMACEUTICALS INC | 30-MAY-11 |
Ceftriaxone | LUPIN PHARMACEUTICALS INC | 08-JUN-11 |
Ceftriaxone | APP Pharmaceuticals , LLC | 20-JUN-11 |
Ceftriaxone | APP Pharmaceuticals , LLC | 20-JUN-11 |
Ceftriaxone | Sagent Pharmaceuticals | 24-JUN-11 |
Ceftriaxone Sodium | Sandoz Inc | 04-AUG-11 |
Ceftriaxone Sodium | Sandoz Inc | 04-AUG-11 |
Ceftriaxone Sodium | Hospira, Inc | 04-AUG-11 |
Ceftriaxone Sodium | Hospira, Inc | 07-OCT-11 |
Ceftriaxone Sodium | Hospira, Inc | 07-OCT-11 |
Ceftriaxone Sodium | Hospira, Inc | 07-OCT-11 |
Ceftriaxone And Dextrose | B. Braun Medical Inc. | 16-NOV-11 |
Ceftriaxone | Baxter Healthcare Corporation | 09-JAN-12 |
Ceftriaxone Sodium | Cardinal Health | 01-FEB-12 |
Ceftriaxone Sodium | Cardinal Health | 01-FEB-12 |
Ceftriaxone | Rebel Distributors Corp | 09-FEB-12 |
Ceftriaxone | APP Pharmaceuticals, LLC | 02-MAR-12 |
Ceftriaxone | Rebel Distributors Corp | 20-MAR-12 |
Ceftriaxone Sodium | Cardinal Health | 03-APR-12 |
Ceftriaxone Sodium | Cardinal Health | 03-APR-12 |
Ceftriaxone Sodium | Cardinal Health | 03-APR-12 |
Ceftriaxone Sodium | Cardinal Health | 03-APR-12 |
Ceftriaxone | Cardinal Health | 12-APR-12 |
Ceftriaxone Sodium | Cardinal Health | 23-APR-12 |
Ceftriaxone | Wockhardt Limited | 02-MAY-12 |
Ceftriaxone | Wockhardt USA LLC. | 02-MAY-12 |
Ceftriaxone | WG Critical Care, LLC | 18-MAY-12 |
Ceftriaxone Sodium | Physicians Total Care, Inc. | 01-JUN-12 |
Ceftriaxone Sodium | Sandoz Inc | 09-JUL-12 |
Ceftriaxone Sodium | Sandoz Inc | 09-JUL-12 |
Ceftriaxone Sodium | Hospira, Inc. | 31-AUG-12 |
Ceftriaxone | Cephazone Pharma LLC | 07-SEP-12 |
Ceftriaxone | West-ward Pharmaceutical Corp | 18-SEP-12 |
Ceftriaxone Sodium | Apotex Corporation | 24-SEP-12 |
Ceftriaxone Sodium | Apotex Corporation | 16-OCT-12 |
Ceftriaxone | WG Critical Care, LLC | 01-JAN-13 |
Ceftriaxone | AGILA SPECIALTIES PRIVATE LIMITED | 10-JAN-13 |
Ceftriaxone | Teva Parenteral Medicines, Inc. | 29-JAN-13 |
Ceftriaxone | Sagent Pharmaceuticals | 04-MAR-13 |
Ceftriaxone | Cardinal Health | 18-APR-13 |
Ceftriaxone Sodium | REMEDYREPACK INC. | 06-MAY-13 |
What Ceftriaxone safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Ceftriaxone. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Ceftriaxone.